$1.00
-0.07-6.45%
Pre-Market: 7:03 PM EDT
Comments
Loading...
Citius Oncology (NASDAQ:CTOR) Stock, Earnings Estimates, EPS, And Revenue
Citius Oncology reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 12
EPS
$-0.060
Quarterly Revenue
$0K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Citius Oncology using advanced sorting and filters.
Data brought to you by Benzinga APIs
Citius Oncology (CTOR) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Citius Oncology (CTOR) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Citius Oncology (NASDAQ:CTOR) reporting earnings?
Citius Oncology (CTOR) is scheduled to report earnings on November 29, 2024. The last reported earnings were for reported on August 12, 2024 for Q3.
What were the latest earnings per share (EPS) for Citius Oncology (NASDAQ:CTOR)?
The Actual EPS was $-0.06, which missed the estimate of $0.00.
What were Citius Oncology’s (NASDAQ:CTOR) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.